blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1648516

EP1648516 - USE OF COMBINATION OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR AND CYTOTOXIC AGENTS FOR TREATMENT AND INHIBITION OF CANCER [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  30.05.2008
Database last updated on 24.08.2024
Most recent event   Tooltip30.05.2008Application deemed to be withdrawnpublished on 02.07.2008  [2008/27]
Applicant(s)For all designated states
Wyeth Holdings Corporation
Five Giralda Farms
Madison, NJ 07940 / US
[2006/17]
Inventor(s)01 / GREENBERGER, Lee, Martin
253 Midland Avenue
Montclair, NJ 07042 / US
02 / DISCAFANI-MARRO, Carolyn, Mary
8 Brookside Avenue
Cortlandt Manor, NY 10567 / US
03 / FROST, Philip
4 Emerson Court
Morris Township, NJ 07960 / US
 [2006/17]
Representative(s)Wileman, David Francis, et al
Wyeth Pharmaceuticals, Huntercombe Lane South, Taplow Maidenhead
Berkshire SL6 OPH / GB
[2006/17]
Application number, filing date04801904.628.07.2004
[2006/17]
WO2004US24478
Priority number, dateUS20030492132P01.08.2003         Original published format: US 492132 P
[2006/17]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005018677
Date:03.03.2005
Language:EN
[2005/09]
Type: A2 Application without search report 
No.:EP1648516
Date:26.04.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 03.03.2005 takes the place of the publication of the European patent application.
[2006/17]
Search report(s)International search report - published on:EP26.05.2006
ClassificationIPC:A61K45/06, A61K31/47, A61P35/00
[2006/17]
CPC:
A61K31/47 (EP,KR,US); A61K45/06 (EP,KR,US); A61P35/00 (EP);
A61P43/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/17]
Extension statesAL19.01.2006
HR19.01.2006
LT19.01.2006
LV19.01.2006
MK19.01.2006
TitleGerman:VERWENDUNG EINER KOMBINATION AUS EINEM EPIDERMALEN WACHSTUMSFAKTOR-REZEPTOR-KINASE-HEMMER UND ZYTOTOXISCHEN MITTELN ZUR BEHANDLUNG UND HEMMUNG VON KREBS[2006/17]
English:USE OF COMBINATION OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR AND CYTOTOXIC AGENTS FOR TREATMENT AND INHIBITION OF CANCER[2006/17]
French:UTILISATION D'UN MELANGE D'UN INHIBITEUR DE LA KINASE DU RECEPTEUR DE FACTEUR DE CROISSANCE EPIDERMIQUE ET D'AGENTS CYTOTOXIQUES DANS LE TRAITEMENT ET L'INHIBITION DE CANCER[2006/17]
Entry into regional phase19.01.2006National basic fee paid 
19.01.2006Designation fee(s) paid 
19.01.2006Examination fee paid 
Examination procedure19.01.2006Amendment by applicant (claims and/or description)
19.01.2006Examination requested  [2006/17]
31.07.2007Despatch of a communication from the examining division (Time limit: M04)
11.12.2007Application deemed to be withdrawn, date of legal effect  [2008/27]
18.01.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2008/27]
Fees paidRenewal fee
10.07.2006Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.07.200704   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XD]US6384051  (FROST PHILIP [US], et al) [XD] 1-5,10,11* column 17, paragraph 3 *;
 [X]WO03020266  (WYETH CORP [US]) [X] 1-6,10,11 * page 8, paragraph 2 - page 9, paragraph 1 *;
 [X]WO03050090  (WYETH CORP [US]) [X] 1-5,10,11 * page 34, paragraph 2 * * page 36, paragraph 2 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.